Actuate Therapeutics
NASDAQ: ACTU
Healthcare
Biotechnology
Rank
#19388
Market Cap
$213.85 M
Volume
32,506
Price
$10.90
Change (%)
5.72%
Country or region
United States
United States
Actuate Therapeutics's latest marketcap:
$213.85 M
As of 05/28/2025, Actuate Therapeutics's market capitalization has reached $213.85 M. According to our data, Actuate Therapeutics is the 19388th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $213.85 M |
| Revenue (ttm) | $0.00 |
| Net Income (ttm) | $-25,306,293.00 |
| Shares Out | 19.62 M |
| EPS (ttm) | $-1.97 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/15/2025 |
Market Cap Chart
Data Updated: 05/28/2025
Actuate Therapeutics's yearly market capitalization.
Actuate Therapeutics has seen its market value grow from $155.47 M to $213.85 M since 2024, representing a total increase of 37.55% and an annual compound growth rate (CAGR) of 118.71%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/28/2025 | $213.85 M | 27.46% |
| 12/31/2024 | $155.47 M |
Company Profile
Frequently Asked Questions
As of 05/28/2025, Actuate Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $213.85 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Actuate Therapeutics global market capitalization ranking is approximately 19388 as of 05/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2015 |
| IPO Date | 08/13/2024 |
| Employees | 10 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address | |
| Website |
